While penile prostheses are generally considered an effective treatment for erectile dysfunction (ED), cases of malpractice litigation do occur at times. Recently, researchers from the Rutgers New Jersey Medical School and Wake Forest School of Medicine discussed such cases in The Journal of Sexual Medicine.
While many neuroimaging studies have shed light on the brain correlates of male sexual behavior, few have looked at brain activity when men’s sexual arousal is inhibited, particularly in the case of psychogenic erectile dysfunction (ED).
A pilot study has found that cognitive-behavioral couples therapy may be helpful for women with provoked vestibulodynia (PVD) and their partners.
For some time, there has been concern among physicians that testosterone therapy either leads to prostate cancer or causes undiagnosed prostate cancer to progress. These beliefs have been shown to be a myth; however, many physicians still cite this concern as the main reason for not prescribing testosterone therapy. The current study aimed to address these concerns and describe the long-term outcomes for 1,365 men who tried different forms of testosterone therapy as part of the UK Androgen Study (UKAS).
Provoked vestibulodynia (PVD) is characterized by pain, tenderness, and redness in the vestibule of the vaginal area. It affects around 12% of women and can be triggered by contact with various stimuli, such as a penis, dildo, speculum, feminine hygiene product, or tight clothing. It is not uncommon for women with PVD to develop sexual dysfunction and to lose interest in even nonpenetrative sex.
This study aims to discuss chronic pain in the context of PVD, analyze PVD’s chronicity and negative sexual sequelae, and examine the roles that cognitive behavioral therapy (CBT) and mindfulness practice can play in PVD’s treatment.
Dyspareunia in women, characterized by recurrent and persistent genital pain at intercourse, is believed to be associated with pelvic floor hyperactivity and decreased sexual arousal. At present, no device exists that can measure pelvic floor activity and genital arousal simultaneously. This study reports on a new vaginal device that can take both measurements at the same time.